First Time Loading...
S

Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233

Watchlist Manager
Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Watchlist
Price: 16.65 CNY -0.42% Market Closed
Updated: May 27, 2024

Shandong Jincheng Pharmaceutical Group Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Jincheng Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Interest Income Expense
-¥873.4k
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
25%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Interest Income Expense
¥71.6m
CAGR 3-Years
-48%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
¥1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
¥134.5m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
¥429.9m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
30%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
¥1.1B
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
37%

See Also

What is Shandong Jincheng Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
-873.4k CNY

Based on the financial report for Mar 31, 2024, Shandong Jincheng Pharmaceutical Group Co Ltd's Interest Income Expense amounts to -873.4k CNY.

What is Shandong Jincheng Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
25%

Over the last year, the Interest Income Expense growth was 95%. The average annual Interest Income Expense growth rates for Shandong Jincheng Pharmaceutical Group Co Ltd have been 69% over the past three years , and 25% over the past ten years .